Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction

Shaowei Li, Xuhua Tang, J Seetharaman, Chunyan Yang, Ying Gu, Jun Zhang, Hailian Du, J Wai Kuo Shih, Choy-Leong Hew, J Sivaraman, Ningshao Xia, Shaowei Li, Xuhua Tang, J Seetharaman, Chunyan Yang, Ying Gu, Jun Zhang, Hailian Du, J Wai Kuo Shih, Choy-Leong Hew, J Sivaraman, Ningshao Xia

Abstract

Hepatitis E virus (HEV), a non-enveloped, positive-stranded RNA virus, is transmitted in a faecal-oral manner, and causes acute liver diseases in humans. The HEV capsid is made up of capsomeres consisting of homodimers of a single structural capsid protein forming the virus shell. These dimers are believed to protrude from the viral surface and to interact with host cells to initiate infection. To date, no structural information is available for any of the HEV proteins. Here, we report for the first time the crystal structure of the HEV capsid protein domain E2s, a protruding domain, together with functional studies to illustrate that this domain forms a tight homodimer and that this dimerization is essential for HEV-host interactions. In addition, we also show that the neutralizing antibody recognition site of HEV is located on the E2s domain. Our study will aid in the development of vaccines and, subsequently, specific inhibitors for HEV.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1. Structure of E2s.
Figure 1. Structure of E2s.
(A) Ribbon diagram of the subunit of the E2s dimer, side view. (B) Top view of the subunit of E2s dimer showing the cavity. β-strands and random coils/turns are depicted in red and green respectively. N- and C-termini are labeled. The dimerization interface and groove region are labeled. (C) The E2s dimer. Subunit A is shown in yellow, subunit B in red. Dimeric interface residues from both subunits are shown in ball-and-stick representation. Notably, the asymmetric unit consists of one subunit of the dimer. This dimer is generated by crystallographic symmetry. These figures were prepared by using Molscript and Raster3D ,. (D) Close-up view of the dimer interface. Key residues involved in the dimerization are labeled. This figure was prepared using PyMol .
Figure 2. Dimerization of E2s in solution…
Figure 2. Dimerization of E2s in solution was investigated by analytical ultracentrifugation (AUC).
(A) Sedimentation velocity experiment shows that E2s behaves as a single globular species having the sedimentation coefficient of 2.55S and a hydrated friction ratio of 1.30. (B) Sedimentation equilibrium experiment indicates that E2s mainly exists as a dimer with M.W. 30,651±421 Da. The dissociation constant of the E2s dimer, Kd was fitted as 397±283 nM using the self-association model.
Figure 3. Stereo view of the electron…
Figure 3. Stereo view of the electron density map.
Simulated annealing Fo-Fc omit map of the C-terminal region of E2s, which is crucial for the dimerization. Residues Val600, Leu601 and all atoms within 2.0 Å were omitted prior to refinement. The map contoured at a level of 3σ. This figure was prepared using PyMol .
Figure 4. Structural comparison of E2s with…
Figure 4. Structural comparison of E2s with P2 domains.
(A) Side-by-side ribbon diagram of HEV-E2s, the SMSV-P2 domain (pdb code 2gh8) and the rNV-P2 domains (Pdb code 1ihm). β-strands and α-helices are numbered. N- and C-termini are also labeled. These figures were prepared using Molscript and Raster3D ,. (B) Topology diagrams of HEV-E2s, the SMSV-P2 domain and the rNV-P2 domain. β-strands, α-helices and connecting loops are represented by red arrows, blue cylinders and green lines respectively.
Figure 5. Mutational studies on the dimer…
Figure 5. Mutational studies on the dimer interface.
(A) The schematic representation of wild-type E2 and eleven point mutations targeting the dimer interface region. Secondary structural elements are shown for the E2s region. The mutated residues located on the β-strands and coils are shown in red and black, respectively. (B) These mutants and wild-type E2 were subjected to non-reducing SDS-PAGE and Western Blotting with the neutralizing mAb 8C11 and 8H3 to study the effects of these mutations on dimerization and neutralization, respectively. [+] denotes dimerization or reactivity with 8C11 or 8H3, [−] denotes loss of the respective property. Note that both the capacity to form dimers and the reactivity with mAb 8C11 and 8H3 were abolished simultaneously in six of these mutants: Y557A, T564A, V598E, A599E, L601E and A602E.
Figure 6. Mapping of site-directed mutation on…
Figure 6. Mapping of site-directed mutation on E2s.
A transparent surface representation of the subunit of the E2s dimer is shown at two different orientations. (A) Shows the dimerization mutants and (B) shows the groove region mutants. Figure 6(B) is 180° rotated with respected to Figure 6(A). Further the view of Figure 6(A) is related to the view of Figure 1(A) with an anticlockwise rotation of 90°. All mutated residues are shown in ball and stick model. Residues playing roles in the E2s dimerization are shown in blue. Residues in the groove region that were mutated to study the reactivity of mAb are shown in magenta. This figure was prepared using PyMol .
Figure 7. Mutational studies on the groove…
Figure 7. Mutational studies on the groove region.
(A) The schematic representation of wild-type E2 and nine point mutations targeting the solvent-accessible residues near the groove region. (B) The wild type E2 and its mutants were subjected to non-reducing SDS-PAGE and Western Blotting with the HEV-neutralizing antibody 8C11 or 8H3. In this figure the lanes with H indicate samples in the reduced condition (i.e. these samples were heated up to 100°C for 3 minutes). These samples were mainly resolved as monomers. The lanes with N indicate samples in the non-reducing condition (i.e. these samples with 0.1% SDS, no BME and were not heated). These samples were resolved mainly as dimers. All nine mutants remained as dimers. Western Blotting showed that the dimeric E2 wild type and eight mutants were reactive with mAb 8C11. Of these, only E479A, Y485A, I529A, K534A and D496A abolished the 8H3 reactivity. Interestingly, mutant D496A abolished the HEV neutralizing antibodies 8C11 and 8H3 reactivity while maintaining the dimeric arrangement.

References

    1. Jaiswal SP, Jain AK, Naik G, Soni N, Chitnis DS. Viral hepatitis during pregnancy. Int J Gynaecol Obstet. 2001;72:103–108.
    1. Pringle CR. Virus taxonomy–1999. The universal system of virus taxonomy, updated to include the new proposals ratified by the International Committee on Taxonomy of Viruses during 1998. Arch Virol. 1999;144:421–429.
    1. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol. 2008;48:494–503.
    1. Worm HC, van der Poel WH, Brandstatter G. Hepatitis E: an overview. Microbes Infect. 2002;4:657–666.
    1. Xing L, Kato K, Li T, Takeda N, Miyamura T, et al. Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes. Virology. 1999;265:35–45.
    1. Li SW, Zhang J, He ZQ, Gu Y, Liu RS, et al. Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J Biol Chem. 2005;280:3400–3406.
    1. He S, Miao J, Zheng Z, Wu T, Xie M, et al. Putative receptor-binding sites of hepatitis E virus. J Gen Virol. 2008;89:245–249.
    1. Zhang J, Gu Y, Ge SX, Li SW, He ZQ, et al. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine. 2005;23:2881–2892.
    1. Li SW, Zhang J, Li YM, Ou SH, Huang GY, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine. 2005;23:2893–2901.
    1. Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol. 2007;372:774–797.
    1. Rossmann MG, Johnson JE. Icosahedral RNA virus structure. Annu Rev Biochem. 1989;58:533–573.
    1. Coulibaly F, Chevalier C, Gutsche I, Pous J, Navaza J, et al. The birnavirus crystal structure reveals structural relationships among icosahedral viruses. Cell. 2005;120:761–772.
    1. Prasad BV, Hardy ME, Dokland T, Bella J, Rossmann MG, et al. X-ray crystallographic structure of the Norwalk virus capsid. Science. 1999;286:287–290.
    1. Chen R, Neill JD, Estes MK, Prasad BV. X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc Natl Acad Sci U S A. 2006;103:8048–8053.
    1. Holm L, Sander C. Touring protein fold space with Dali/FSSP. Nucleic Acids Res. 1998;26:316–319.
    1. Tan M, Huang P, Meller J, Zhong W, Farkas T, et al. Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. J Virol. 2003;77:12562–12571.
    1. Tan M, Hegde RS, Jiang X. The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J Virol. 2004;78:6233–6242.
    1. Chakravarty S, Hutson AM, Estes MK, Prasad BV. Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J Virol. 2005;79:554–568.
    1. Zhang JZ, Ng MH, Xia NS, Lau SH, Che XY, et al. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J Med Virol. 2001;64:125–132.
    1. Luo WX, Zhang J, Yang HJ, Li SW, Xie XY, et al. [Construction and application of an Escherichia coli high effective expression vector with an enhancer]. Sheng Wu Gong Cheng Xue Bao. 2000;16:578–581.
    1. Otwinowski A, Minor W. Processing of X-ray Diffraction Data Collected in Oscillation Mode. Methods Enzymol. 1997;276:307–326.
    1. Weeks CM, Miller R. The design and implementation of SnB v2.0. J Appl Cryst. 1999;32:120–124.
    1. Terwilliger T. SOLVE and RESOLVE: automated structure solution, density modification and model building. J Synchrotron Radiat. 2004;11:49–52.
    1. Terwilliger TC. SOLVE and RESOLVE: automated structure solution and density modification. Methods Enzymol. 2003;374:22–37.
    1. Perrakis A, Morris R, Lamzin VS. Automated protein model building combined with iterative structure refinement. Nat Struct Biol. 1999;6:458–463.
    1. Jones TA, Zou JY, Cowan SW, Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991;47 ( Pt 2):110–119.
    1. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr. 1998;54:905–921.
    1. Lakowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK - a program to check the stereochemical quality of protein structures. J Appl Crystallogr. 1993;26:283–291.
    1. Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J. 2000;78:1606–1619.
    1. Johnson ML, Correia JJ, Yphantis DA, Halvorson HR. Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques. Biophys J. 1981;36:575–588.
    1. Laemmli UK, Beguin F, Gujer-Kellenberger G. A factor preventing the major head protein of bacteriophage T4 from random aggregation. J Mol Biol. 1970;47:69–85.
    1. Merritt EA, Bacon DJ. Raster3D: photorealistic molecular graphics. Methods Enzymol. 1997;277:505–524.
    1. Merritt EA, Murphy ME. Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D Biol Crystallogr. 1994;50:869–873.
    1. Delano WS. The PyMOL molecular graphics system. San Carlos, CA: Delano Scientific; 2002.

Source: PubMed

3
S'abonner